Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 1 February 2018, 10:00 HKT/SGT
Share:
    

Source: MIMS Singapore
MIMS Announces Growth, Expansion to New Office in Taiwan

SINGAPORE, Feb 1, 2018 - (Media OutReach) - MIMS, a leading multichannel provider of drug information, medical communications and technology solutions in Asia Pacific, is pleased to announce the opening of a new branch office in Taiwan located at 20th floor, No.97, SEC.2, Dun Hua S. Rd., Taipei, Taiwan.

The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry. The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.

"MIMS brings to Taiwan deep expertise in medical communications and strategy," stated Victor Wright, Regional VP of Medical Communications APAC. "MIMS takes pride in bringing exceptional scientific content and events management along with rigorous editorial standards and strict regulatory compliance. It's an exciting opportunity for MIMS to provide best-in-class solutions to the Taiwan pharmaceutical industry."

Prior to the official opening in Taipei, MIMS has offered these services to several multinational pharmaceutical companies in Taiwan.

MIMS has a leading position in the Asia-Pacific healthcare landscape, anchored in its drug reference publications historically. In the past decade, it has evolved to develop progressive digital solutions to empower doctors and healthcare communities to improve patient outcomes.

About MIMS Group

Established in 1963, MIMS is a multichannel provider of drug information, medical education and digital solutions connecting healthcare communities. Our work empowers healthcare communities to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 13 countries (including Taiwan) across Asia Pacific region with approximately two million healthcare professional subscribers to its drug & resource portal, digital and print publications.

Contact:
MIMS Taiwan office address is 20th floor., No. 97, SEC. 2, Dun Hua S. Rd., Taipei, Taiwan. Telephone number: +886 (02) 2709 0611

For more information about the MIMS Taiwan office, please contact Victor Wright at +852 6463-1177, victor.wright@mims.com.


Topic: Press release summary
Source: MIMS Singapore


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 26, 2024 23:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 26, 2024 22:25 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting  
Apr 26, 2024 13:16 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: